Indiana University School of Medicine scientists have identified a new way to weaken pancreatic cancer’s defenses by targeting two key proteins that help the deadly disease resist treatment. The study, recently published in Redox Biology, revealed that a drug combination blocking the proteins together may offer a more effective strategy against pancreatic cancer and potentially other aggressive cancers.
This article was originally published on MedicalXpress.com